CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-10 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion | +8,133 | 151,270 | ||
| 2023-02-10 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −2,951 | $48.92 | $144K | 148,319 |
| 2023-02-10 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Restricted Stock Units | −8,133 | 8,133 | ||
| 2023-02-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion | +2,503 | 6,548 | ||
| 2023-02-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,392 | $48.92 | $68K | 5,156 |
| 2023-02-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −2,503 | 2,502 | ||
| 2023-02-10 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +31,281 | 618,458 | ||
| 2023-02-10 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −16,469 | $48.92 | $806K | 601,989 |
| 2023-02-10 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Restricted Stock Units | −31,281 | 31,281 | ||
| 2023-02-09 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2023-02-09 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $50.40 | $504K | 587,177 |
| 2023-02-09 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 30,000 |
| 2023-02-08 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2023-02-08 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $51.36 | $514K | 587,177 |
| 2023-02-08 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 40,000 |
| 2023-02-07 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
| 2023-02-07 | Torley Helen PRESIDENT AND CEO | Sale | −10,000 | $51.26 | $513K | 587,177 |
| 2023-02-07 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 50,000 |
| 2023-02-03 | Duncan Barbara Gayle Director | Grant or award | +1,188 | 1,188 | ||
| 2023-01-19 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +10,000 | $14.66 | $147K | 597,177 |
Page 42 of 48 · 944 trades